High materiality7/10
Cantor Fitzgerald Reiterates Overweight Rating on Pharvaris B.V. (PHVS)
Why it may matterVerify against the original reporting
upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald reiterates overweight; Target: $65; Posted price: $39.71; Upside ~64%.
- Target: $65; Price: $39.71; Upside ~64%
- Firm: Cantor Fitzgerald
Key facts
- 01
Target: $65
- 02
Posted price: $39.71
- 03
Analyst firm: Cantor Fitzgerald
- 04
Analyst: Steven Seedhouse
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.